MeiraGTx Holdings Plc (MGTX)
13.82
-0.32
(-2.26%)
USD |
NASDAQ |
Aug 28, 16:00
13.82
0.00 (0.00%)
After-Hours: 20:00
MeiraGTx Holdings EPS Diluted (Quarterly) : 1.713 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.713 |
| March 31, 2026 | -0.5696 |
| December 31, 2025 | 0.186 |
| September 30, 2025 | -0.624 |
| June 30, 2025 | -0.4814 |
| March 31, 2025 | -0.5059 |
| December 31, 2024 | -0.5026 |
| September 30, 2024 | -0.549 |
| June 30, 2024 | -0.7552 |
| March 31, 2024 | -0.3191 |
| December 31, 2023 | 0.3178 |
| September 30, 2023 | -0.7442 |
| June 30, 2023 | -0.5344 |
| March 31, 2023 | -0.6243 |
| September 30, 2022 | -0.8343 |
| June 30, 2022 | -0.7606 |
| March 31, 2022 | -0.6976 |
| December 31, 2021 | -0.223 |
| Date | Value |
|---|---|
| September 30, 2021 | -0.5874 |
| June 30, 2021 | -0.4551 |
| March 31, 2021 | -0.5371 |
| December 31, 2020 | -0.2506 |
| September 30, 2020 | -0.1728 |
| June 30, 2020 | -0.6875 |
| March 31, 2020 | -0.4282 |
| December 31, 2019 | -0.149 |
| September 30, 2019 | -0.3018 |
| June 30, 2019 | -0.6343 |
| March 31, 2019 | -0.6249 |
| December 31, 2018 | -0.7689 |
| September 30, 2018 | -0.5856 |
| June 30, 2018 | -2.29 |
| March 31, 2018 | -0.611 |
| September 30, 2017 | -0.3176 |
| June 30, 2017 | -0.2581 |
| March 31, 2017 | -0.245 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Xencor, Inc. | -0.2864 |
| UroGen Pharma Ltd. | -0.2848 |
| IDEAYA Biosciences, Inc. | -1.222 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 160.67M |
| Revenue (Quarterly) | 321.43M |
| Total Expenses (Quarterly) | 160.71M |
| Enterprise Value | 1.271B |
| Gross Profit Margin (Quarterly) | 96.89% |
| Profit Margin (Quarterly) | 49.99% |
| Earnings Yield | 5.11% |
| Operating Earnings Yield | 15.68% |
| Normalized Earnings Yield | 5.019 |